Some fertility treatments can increase the chance of twins, but there is no single “fertility treatment twin rate.” The effect depends on what treatment is used and what happens during that treatment. Ovulation-inducing medicines can lead to more than one mature follicle and more than one egg being released, while the twin probability with in vitro fertilization (IVF) is strongly influenced by how many embryos are transferred.
Modern single embryo transfer has greatly reduced IVF-related multiple births, although transferring one embryo does not reduce the chance to zero because a single embryo can occasionally split and develop into identical twins. For an individual treatment cycle, factors such as ovarian response, number of mature follicles, medication, age, and embryo-transfer strategy matter more than a single population-wide percentage.
Quick answer: Fertility treatment can increase twin probability through three main pathways: more than one egg is released, more than one embryo is transferred, or a single embryo splits after fertilization.
Quick Treatment Comparison
| Treatment or Situation | Main Route to Twins | Key Variable | General Effect on Twin Probability |
|---|---|---|---|
| Natural conception | Natural multiple ovulation or spontaneous embryo splitting | Individual biology | Baseline |
| Unmedicated IUI | Usually the same biological routes as natural conception | Natural ovulation | Generally close to the person’s natural baseline |
| Clomiphene citrate (Clomid) | More than one follicle may mature | Ovarian response and follicle number | Increased |
| Letrozole | More than one follicle may mature | Ovarian response and follicle number | Can be increased |
| Injectable gonadotropins | Multiple follicular development | Number and size of developing follicles | Can be substantially increased when multiple follicles develop |
| Stimulated IUI | More than one egg may be available for fertilization | Medication and mature follicle count | Higher than an equivalent unmedicated cycle when multiple follicles develop |
| IVF with single embryo transfer (SET/eSET) | Occasional splitting of one embryo | Monozygotic twinning | Much lower multiple-pregnancy risk than transferring multiple embryos, but not zero |
| IVF with more than one embryo transferred | More than one embryo may implant | Number of embryos transferred and implantation | Higher |
This table describes the main mechanisms rather than assigning one universal percentage to each treatment. Actual rates vary by population, treatment protocol, age, ovarian response, embryo-transfer practice, country, study period, and the outcome being measured.
For context: ASRM patient guidance reports that multiple-gestation risk can be about 8% with clomiphene citrate and as high as 30% with gonadotropins used to induce ovulation. The same guidance emphasizes that medication type alone does not determine risk: age and, especially, the number of follicles produced also matter. These figures describe population-level multiple-gestation risk and should not be interpreted as an individual’s predicted chance of twins.
Why Fertility Treatments Can Increase the Chance of Twins
Fertility treatment does not increase twin probability through one single mechanism. Most treatment-related twin pregnancies can be understood through three pathways. Separating these pathways makes it easier to understand why treatments such as IUI, fertility medication, and IVF do not carry the same type of twin risk.
Pathway 1: More Than One Egg Is Released
Ovulation induction and ovarian stimulation can encourage more than one ovarian follicle to develop. A follicle is the fluid-filled structure in the ovary in which an egg develops. If several follicles reach maturity, more than one egg may be released during ovulation.
If two separate eggs are fertilized and both pregnancies continue, the result is dizygotic twins, usually called fraternal twins. This is the principal mechanism behind treatment-related twins in many medication-assisted cycles, including stimulated IUI.
The medication name alone does not determine what will happen. The ovarian response matters. One mature follicle represents a different clinical situation from a cycle in which several mature follicles have developed.
Pathway 2: More Than One Embryo Is Transferred
IVF creates a different pathway. Eggs are fertilized outside the body and one or more embryos are subsequently transferred to the uterus. If more than one embryo is transferred and more than one implants, a multiple pregnancy can result.
When two separately created embryos implant, the twins are generally dizygotic. This is why the number of embryos transferred has historically been one of the most important modifiable factors affecting IVF-related twin and higher-order multiple pregnancy.
Pathway 3: One Embryo Splits
Twins are still possible when only one embryo is transferred. A single embryo can occasionally divide into two developing embryos. This produces monozygotic twins, more commonly known as identical twins.
This is an important limitation of single embryo transfer. SET greatly reduces the pathway in which two transferred embryos both implant, but it cannot eliminate spontaneous embryo splitting.
Fertility Drugs and Twin Probability
Fertility medications can influence twin probability by changing ovulation and follicular development. Some treatments aim to induce ovulation when it is not occurring regularly, while others stimulate the ovaries so that one or more follicles develop.
The important clinical question is therefore not simply, “Which drug was used?” It is also, “How did the ovaries respond?” The number of mature follicles produced during a treatment cycle is a major determinant of the possibility that more than one egg will be available for fertilization.
Clomiphene Citrate / Clomid
Clomiphene citrate, commonly known by the brand name Clomid, is an oral medication used to induce or stimulate ovulation. Some treatment cycles produce a single dominant follicle, while others produce more than one mature follicle.
When multiple follicles develop and more than one egg is released, two eggs can potentially be fertilized. This is why clomiphene treatment is associated with a higher multiple-gestation risk than would be expected from a typical single-ovulation cycle.
That does not mean everyone taking clomiphene has the same chance of twins. Age, reason for treatment, dose, ovarian response, follicle number, and whether the medication is combined with intercourse or insemination all affect how population statistics should be interpreted.
Letrozole
Letrozole is another oral medicine used for ovulation induction. It works differently from clomiphene but can also result in the development of one or more mature follicles.
Twin pregnancy is therefore possible during a letrozole cycle, but the treatment should not be assigned one universal twin percentage. Published multiple-pregnancy rates differ across patient populations and protocols. Professional fertility guidance also indicates that multiple-gestation risk is generally lower with carefully managed oral ovulation-induction treatment than with gonadotropin stimulation that produces multiple follicles.
Injectable Gonadotropins
Gonadotropins are injectable fertility medications that contain follicle-stimulating hormone (FSH), sometimes together with luteinizing hormone (LH) activity. They can stimulate the ovaries more directly than oral ovulation-induction medicines.
If several follicles develop, several eggs may become available for ovulation and fertilization. For this reason, gonadotropin-stimulated cycles can carry a substantial risk of twins or higher-order multiples when ovarian response is not carefully controlled.
Professional fertility guidance emphasizes conservative dosing, monitoring, and cancellation criteria because the aim is not simply to produce as many follicles as possible. In ovulation induction, the preferred response is often development of a single mature egg.
Why the Number of Mature Follicles Matters
A mature follicle is not the same thing as a guaranteed egg, pregnancy, or baby. A follicle may not release an egg, an egg may not fertilize, and an implanted pregnancy may not continue. Even so, mature follicle count provides important information about how many eggs could potentially be available during an ovulation-induction or stimulated IUI cycle.
This creates a simple relationship:
- Fertility medication stimulates follicular development.
- More than one follicle may become mature.
- More than one egg may be released.
- More than one egg may be fertilized.
- If two resulting pregnancies continue, fraternal twins can result.
This is why two people taking the same medication can have very different multiple-pregnancy risk. Their ovaries may respond very differently to the same general treatment approach.
IUI and the Chance of Twins
Intrauterine insemination (IUI) is often associated with twins, but it is important to separate the insemination procedure from the ovarian stimulation that may accompany it.
IUI places prepared sperm into the uterus around the time of ovulation. The procedure itself does not create additional eggs. Much of the treatment-related increase in twin probability occurs when fertility medication is used before IUI and more than one mature follicle develops.
Unmedicated IUI vs Stimulated IUI
| Feature | Unmedicated IUI | Stimulated IUI |
|---|---|---|
| Ovulation | Relies largely on the person’s natural cycle | Medication is used to induce or stimulate ovulation |
| Number of follicles | Often reflects natural follicular development | One or several mature follicles may develop |
| Main treatment-related twin mechanism | No additional egg is created by the insemination procedure itself | Multiple eggs may be released and fertilized |
| Important variable | Natural ovulation pattern | Medication, ovarian response, and mature follicle count |
The distinction matters because quoting one “IUI twin rate” can conceal very different treatment protocols. An unmedicated IUI cycle and a gonadotropin-stimulated IUI cycle should not automatically be treated as equivalent exposures.
Why Follicle Monitoring Matters During IUI
Clinicians may use ultrasound and other monitoring during stimulated cycles to assess follicular growth and ovarian response. Monitoring can help identify a cycle in which more follicles are developing than intended.
If the ovarian response creates an unacceptably high risk of twins, triplets, or higher-order multiples, treatment may be adjusted or the cycle may be cancelled. Depending on the clinical situation, patients may also be advised not to proceed with insemination or timed intercourse during that cycle.
The exact cancellation threshold is a clinical decision and should not be inferred from a general-information page. Follicle size, number, age, treatment indication, medication, and other patient-specific factors all influence that decision.
IVF and Twin Probability
IVF has a strong historical association with twins, but modern IVF should not automatically be equated with a high twin rate. The most important distinction is between transferring one embryo and transferring more than one.
Why IVF Historically Produced More Twins
Earlier IVF practice more commonly involved transferring multiple embryos in an attempt to improve the chance that at least one would implant. The consequence was that two or more transferred embryos could implant during the same cycle, producing twins, triplets, or other multiple pregnancies.
Official data from the UK Human Fertilisation and Embryology Authority (HFEA) show how dramatically IVF practice has changed. The average UK IVF multiple-birth rate was around 28% in the early 1990s but had fallen to 3.4% in 2023. Over the same broad period, single embryo transfer became increasingly common and accounted for 88% of UK IVF cycles in 2023.
Those figures describe UK multiple births, not an individual’s personal probability of twins. Their main value here is historical: they show why older IVF statistics can give a very different impression from modern single-embryo-transfer practice.
Single Embryo Transfer and Modern IVF
Single embryo transfer (SET) means transferring one embryo to the uterus. When the decision to transfer one embryo is made electively, the term elective single embryo transfer (eSET) is often used.
SET removes the specific pathway in which two separately transferred embryos both implant. This is why professional ART guidance promotes single embryo transfer in appropriate patients as a major strategy for reducing twin and higher-order multiple pregnancies.
Embryo selection can support this strategy by helping a fertility team choose a single embryo with a favorable prognosis. Techniques such as preimplantation genetic testing may influence embryo-selection decisions in some treatment settings, but they should not be interpreted as independently guaranteeing a singleton pregnancy.
Multiple Embryo Transfer
When more than one embryo is transferred, more than one embryo may implant. Transferring two embryos therefore creates a route to twins that does not exist when only one embryo is transferred.
It does not mean twins will occur. Neither embryo may implant, one may implant, both may implant, or a pregnancy may begin and later change. The number transferred changes the opportunity for multiple implantation, not the certainty of the outcome.
Age, embryo characteristics, treatment history, prognosis, and clinic-specific practice can all influence embryo-transfer decisions. Because multiple gestation carries additional risks, professional fertility organizations recommend limits on the number of embryos transferred and encourage singleton pregnancy where clinically appropriate.
Can One Embryo Become Twins?
Yes. A single transferred embryo can occasionally split and produce monozygotic, or identical, twins. This means that SET reduces multiple-pregnancy risk but cannot make it zero.
A 2025 analysis of 154,671 live births following autologous single embryo transfer in Australia and New Zealand estimated monozygotic twinning in 1.5% of live births after SET. The study also found that blastocyst-stage transfer was associated with higher odds of monozygotic twinning than cleavage-stage transfer.
That result should be interpreted in context. The study was retrospective, covered treatment from 2009 through 2021, and estimated zygosity rather than confirming every case with DNA testing. The precise biological mechanisms behind ART-associated embryo splitting remain an area of research.
What Determines Your Individual Twin Probability?
A population statistic cannot tell one person exactly what will happen during a fertility-treatment cycle. Individual probability is shaped by several interacting factors.
Treatment Type and Medication
An IVF cycle, an unmedicated IUI cycle, an oral ovulation-induction cycle, and a gonadotropin-stimulated cycle create different opportunities for multiple pregnancy. Even within the same broad treatment category, dose and protocol can alter ovarian response.
Number of Mature Follicles
For treatments involving ovulation induction or ovarian stimulation, mature follicle number is one of the most important clinical variables. Multiple follicular development increases the possibility that more than one egg will be released and fertilized.
Maternal Age and Ovarian Response
Age can influence both reproductive biology and response to treatment. It can also affect clinical decisions about stimulation and embryo transfer. However, age should not be interpreted in isolation. In a treatment cycle, ovarian response, follicle count, embryo characteristics, and transfer strategy may be more direct determinants of treatment-related multiple pregnancy.
Number of Embryos Transferred
During IVF, embryo-transfer number is a major modifiable factor. Transferring one embryo greatly limits the route to dizygotic IVF twins, while transferring more than one creates the possibility that multiple embryos will implant.
This is why “IVF” alone is not enough information to estimate twin probability. An IVF cycle using eSET is clinically different from a cycle in which two embryos are transferred.
Why Fertility-Treatment Twin Percentages Differ Between Sources
It is common to find apparently conflicting fertility-treatment twin statistics online. Often, the numbers are not truly measuring the same thing.
Per Cycle vs Per Transfer vs Per Pregnancy
A percentage can use several different denominators:
- Per treatment cycle: the denominator includes treatment cycles that may never result in pregnancy.
- Per insemination cycle: the denominator includes IUI procedures performed.
- Per embryo transfer: the denominator begins at the IVF transfer stage rather than at the start of treatment.
- Per clinical pregnancy: the percentage describes pregnancies meeting the study’s clinical definition.
- Per live birth: the denominator includes pregnancies that resulted in a live birth.
A twin percentage per pregnancy can therefore be very different from a twin percentage per treatment cycle even when both statistics come from the same clinical program.
Twin Pregnancy vs Twin Birth
A twin pregnancy rate and a twin birth rate are not interchangeable. Some pregnancies that begin with two gestational sacs or embryos do not result in two babies being born. Likewise, some reports combine twins, triplets, and higher-order pregnancies into a single multiple gestation or multiple birth measure.
Before comparing two percentages, check whether both sources are measuring twins specifically and whether both are measuring pregnancy or birth.
Historical vs Current Treatment Practice
IVF statistics are especially sensitive to the year in which the treatment occurred. Multiple embryo transfer was more common historically. Modern practice in many fertility systems places much greater emphasis on single embryo transfer.
The HFEA trend from around 28% IVF multiple births in the early 1990s to 3.4% in 2023 demonstrates why an older statistic should not automatically be applied to a current IVF cycle.
Geography and Clinic Protocol
National guidance, clinic policies, patient populations, access to embryo freezing, use of SET, medication protocols, and cancellation practices differ between countries and clinics. A registry statistic from one health system may be excellent evidence for that population while still being an imperfect estimate for a patient receiving treatment elsewhere.
Population Statistics vs Individual Probability
Population data are useful for understanding trends and relative differences between treatments. They are not a personalized prediction.
For example, two people undergoing stimulated IUI may have different numbers of mature follicles. Two people undergoing IVF may transfer different numbers or types of embryos. A single population percentage cannot capture those differences.
How to read a fertility-treatment twin statistic: Ask what treatment was used, whether medication was involved, how many follicles or embryos were present, what outcome was measured, what population was studied, and when the treatment occurred.
How Fertility Clinics Reduce Multiple-Pregnancy Risk
Modern fertility care generally aims to achieve a healthy pregnancy while minimizing avoidable twin and higher-order multiple gestation. The strategy depends on the type of treatment.
- Follicle monitoring: ultrasound can be used to assess how many follicles are developing during ovulation-induction or stimulation cycles.
- Medication adjustment: stimulation protocols may be modified according to ovarian response.
- Cycle cancellation: a cycle may be stopped when excessive follicular development creates an unacceptable multiple-pregnancy risk.
- Single embryo transfer: SET or eSET reduces IVF multiples caused by multiple implantation.
- Embryo selection: selecting one embryo with a favorable prognosis can support a single-embryo-transfer strategy.
- Limits on embryos transferred: professional guidance places limits on embryo number according to clinical circumstances and prognosis.
These strategies also explain why modern treatment statistics can differ markedly from older fertility-treatment data. Treatment practice itself has changed.
Why Doctors Usually Aim for a Singleton Pregnancy
Twins can result in healthy births, but a twin pregnancy carries greater medical risk than a comparable singleton pregnancy. Professional fertility guidance therefore treats prevention of avoidable multiple gestation as an important treatment goal.
Multiple pregnancy is associated with a greater risk of preterm birth and low birth weight, as well as maternal complications such as hypertensive disorders, preeclampsia, and gestational diabetes. Risks generally increase further with triplets and higher-order multiples.
Some complications also depend on how twins develop. For example, twin-to-twin transfusion syndrome (TTTS) can occur in monochorionic identical twin pregnancies in which the babies share a placenta. It is not a complication of every twin pregnancy.
The purpose of discussing these risks is not to imply that a twin pregnancy will have complications. It explains why contemporary fertility care usually prioritizes one healthy baby at a time rather than treating twins as a more successful outcome.
What Fertility-Treatment Statistics Can and Cannot Tell You
Fertility-treatment statistics are useful when they are interpreted within their limits.
They can help show that some treatment approaches carry more multiple-pregnancy risk than others, that risk changes with follicular response or embryo-transfer strategy, and that modern ART practice has reduced treatment-related multiple births in many settings.
They cannot tell an individual exactly whether twins will occur. A personalized assessment may require information that a general webpage does not have, including treatment indication, medication and dose, ovarian response, mature follicle count, embryo characteristics, age, previous treatment response, and number of embryos transferred.
For that reason, a percentage on this page or any other general resource should be interpreted as population-level context rather than a guarantee or individualized medical prediction.
Frequently Asked Questions
Can fertility treatment guarantee twins?
No. Fertility treatment can alter the probability of twins, but it cannot guarantee them. Multiple eggs or embryos do not ensure multiple implantation or birth, and a single embryo can occasionally split unexpectedly.
Which fertility treatment has the highest chance of twins?
There is no universally correct ranking that applies to every patient. Gonadotropin-stimulated cycles can carry substantial multiple-gestation risk when several follicles develop, while IVF risk depends heavily on the number of embryos transferred. The treatment protocol and individual response matter more than the treatment name alone.
Does IUI itself cause twins?
IUI does not create additional eggs. The greater twin risk seen in many IUI cycles is largely associated with ovarian-stimulation medication that allows more than one mature follicle and egg to develop. An unmedicated IUI cycle is therefore different from a stimulated IUI cycle.
Can one IVF embryo become identical twins?
Yes. A single transferred embryo can split and develop into monozygotic, or identical, twins. This is why single embryo transfer greatly reduces multiple-pregnancy risk but does not eliminate it completely.
Does Clomid increase the chance of twins?
Clomiphene citrate can increase the possibility of twins because more than one follicle may mature and more than one egg may be released. Actual risk varies with ovarian response, follicle number, age, and treatment protocol.
Does letrozole increase twin probability?
Twin pregnancy is possible with letrozole because the medication can result in more than one mature follicle. The probability varies by patient and protocol, so a single universal letrozole twin percentage should not be assumed.
Do fertility injections increase twin probability?
Injectable gonadotropins can substantially increase multiple-gestation risk when they stimulate several follicles to develop. This is why careful dosing, follicle monitoring, and appropriate cycle-cancellation criteria are important parts of gonadotropin treatment.